Award
Purchase Order #75N98026P00452
Purchase Order Awarded to BioLegend, Inc. for Oncology Research Reagents
Buyer
National Institutes of Health
Award Amount
$16,488.00
Ceiling
$16,488.00
Awarded
May 07, 2026
Period of Performance
May 07, 2026 – Sep 30, 2026
Identifier
75N98026P00452
NAICS
325414
This contract represents a purchase order awarded to BioLegend, Inc., a biotechnology company specializing in life science research products. The order procures the TotalSeq-D Human Heme Oncology Cocktail, a specialized reagent mixture used in oncology research to enable advanced cellular analysis. The contract is significant for supporting critical cancer research initiatives by supplying essential tools that facilitate molecular and cellular investigations. The scope covers delivery of the oncology cocktail reagents to a location in San Diego, supporting ongoing research efforts. The award was granted through a standard purchase order process, likely reflecting a competitive and streamlined procurement for research supplies. The performance period is a short-term agreement extending over several months within a single year, ensuring timely availability of the reagents for research activities. No additional contract vehicles, acquisition programs, subcontractors, or prior contracts were indicated.
Description
TOTALSEQ-D HUMAN HEME ONCOLOGY COCKTAIL BIOLEGEND INC:1135351 [26-004804]